Ventyx Net Income From Continuing Ops from 2010 to 2024

VTYX Stock  USD 2.65  0.11  4.33%   
Ventyx Biosciences Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, Ventyx Biosciences Net Loss regression line of annual values had significance of  0.0005 and arithmetic mean of (41,159,390). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-181.4 M
Current Value
-172.4 M
Quarterly Volatility
63.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 15.4 M, Depreciation And Amortization of 150.1 K or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.62. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.
  
Check out the analysis of Ventyx Biosciences Correlation against competitors.
For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Latest Ventyx Biosciences' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Ventyx Biosciences over the last few years. It is Ventyx Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ventyx Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Ventyx Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(41,159,390)
Coefficient Of Variation(154.97)
Mean Deviation50,841,239
Median(4,327,000)
Standard Deviation63,784,586
Sample Variance4068.5T
Range177.1M
R-Value(0.79)
Mean Square Error1658.1T
R-Squared0.62
Significance0.0005
Slope(11,244,507)
Total Sum of Squares56958.6T

Ventyx Net Income From Continuing Ops History

2024-172.4 M
2023-181.4 M
2022-108.4 M
2021-83.7 M
2020-28.2 M

About Ventyx Biosciences Financial Statements

Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-181.4 M-172.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.